Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association
Rodica Pop‐Busui, James L. Januzzi, Dennis Bruemmer, et al.
Diabetes Care (2022) Vol. 45, Iss. 7, pp. 1670-1690
Open Access | Times Cited: 221

Showing 1-25 of 221 citing articles:

2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction
M. Kittleson, Gurusher Panjrath, Kaushik Amancherla, et al.
Journal of the American College of Cardiology (2023) Vol. 81, Iss. 18, pp. 1835-1878
Open Access | Times Cited: 225
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association
Chiadi E Ndumele, Ian J. Neeland, Katherine R. Tuttle, et al.
Circulation (2023) Vol. 148, Iss. 20, pp. 1636-1664
Open Access | Times Cited: 193
Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association
Sadiya S. Khan, Josef Coresh, Michael Pencina, et al.
Circulation (2023) Vol. 148, Iss. 24, pp. 1982-2004
Closed Access | Times Cited: 167
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2024
Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, et al.
Diabetes Care (2023) Vol. 47, Iss. Supplement_1, pp. S179-S218
Open Access | Times Cited: 161
Practical algorithms for early diagnosis of heart failure and heart stress using NT‐proBNP: A clinical consensus statement from the Heart Failure Association of the ESC
Antoni Bayés‐Genís, Kieran F. Docherty, Mark C. Petrie, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 11, pp. 1891-1898
Open Access | Times Cited: 77
Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases
Yehuda Handelsman, Javed Butler, George L. Bakris, et al.
Journal of Diabetes and its Complications (2023) Vol. 37, Iss. 2, pp. 108389-108389
Open Access | Times Cited: 39
High-sensitivity troponins and mortality in the general population
John W. McEvoy, Natalie Daya, Olive Tang, et al.
European Heart Journal (2023) Vol. 44, Iss. 28, pp. 2595-2605
Open Access | Times Cited: 39
Visceral Adipose Tissue: The Hidden Culprit for Type 2 Diabetes
Sneha Dhokte, Krzysztof Czaja
Nutrients (2024) Vol. 16, Iss. 7, pp. 1015-1015
Open Access | Times Cited: 25
Contemporary pharmacological treatment and management of heart failure
Biykem Bozkurt
Nature Reviews Cardiology (2024) Vol. 21, Iss. 8, pp. 545-555
Closed Access | Times Cited: 24
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025
Nuha A. ElSayed, Rozalina G. McCoy, Grazia Aleppo, et al.
Diabetes Care (2024) Vol. 48, Iss. Supplement_1, pp. S207-S238
Closed Access | Times Cited: 21
Cardiovascular and Kidney Risks in Individuals With Type 2 Diabetes: Contemporary Understanding With Greater Emphasis on Excess Adiposity
Naveed Sattar, Calum Presslie, Martin K. Rutter, et al.
Diabetes Care (2024) Vol. 47, Iss. 4, pp. 531-543
Open Access | Times Cited: 16
Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trial
Jawad H. Butt, Pardeep S. Jhund, Alasdair Henderson, et al.
The Lancet Diabetes & Endocrinology (2025)
Open Access | Times Cited: 2
Predicting and preventing heart failure in type 2 diabetes
Ambarish Pandey, Muhammad Shahzeb Khan, Kershaw V. Patel, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 8, pp. 607-624
Closed Access | Times Cited: 34
The role of mitochondria in myocardial damage caused by energy metabolism disorders: From mechanisms to therapeutics
Aolin Li, Lu Lian, Xin-nong Chen, et al.
Free Radical Biology and Medicine (2023) Vol. 208, pp. 236-251
Closed Access | Times Cited: 32
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis
Alessandro Villaschi, Giuseppe Ferrante, F. Cannata, et al.
Clinical Research in Cardiology (2024) Vol. 113, Iss. 6, pp. 898-909
Closed Access | Times Cited: 10
Unveiling Green Synthesis and Biomedical Theranostic paradigms of Selenium Nanoparticles (SeNPs) - A state-of-the-art comprehensive update
Sagnik Nag, Shinjini Kar, Shatakshi Mishra, et al.
International Journal of Pharmaceutics (2024) Vol. 662, pp. 124535-124535
Open Access | Times Cited: 10
Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial
James L. Januzzi, Stefano Del Prato, Julio Rosenstock, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Pathophysiology and Advances in the Therapy of Cardiomyopathy in Patients with Diabetes Mellitus
Patryk Graczyk, Aleksandra Dach, Kamil Dyrka, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 5027-5027
Open Access | Times Cited: 9
Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy
James L. Januzzi, Javed Butler, Stefano Del Prato, et al.
Journal of the American College of Cardiology (2024) Vol. 84, Iss. 2, pp. 137-148
Closed Access | Times Cited: 8
Prevalence of diabetic cardiomyopathy in patients with type 2 diabetes in a large academic medical center
Iwona Świątkiewicz, Neeja Patel, MaryAnn Villarreal-Gonzalez, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases
Petar Seferović, Walter J. Paulus, Giuseppe Rosano, et al.
European Journal of Heart Failure (2024)
Closed Access | Times Cited: 8
The conundrum of diabetic neuropathies—Past, present, and future
Lynn Ang, Kara Mizokami‐Stout, Stéphanie Eid, et al.
Journal of Diabetes and its Complications (2022) Vol. 36, Iss. 11, pp. 108334-108334
Open Access | Times Cited: 30
Mineralocorticoid receptor antagonists with sodium–glucose co-transporter-2 inhibitors in heart failure: a meta-analysis
Mainak Banerjee, Indira Maisnam, Rimesh Pal, et al.
European Heart Journal (2023) Vol. 44, Iss. 37, pp. 3686-3696
Open Access | Times Cited: 21
Trends in heart failure between 2016 and 2022 in Türkiye (TRends-HF): a nationwide retrospective cohort study of 85 million individuals across entire population of all ages
Ahmet Çelik, Dilek Ural, Anıl Şahin, et al.
The Lancet Regional Health - Europe (2023) Vol. 33, pp. 100723-100723
Open Access | Times Cited: 21
Prognostic benefit of early diagnosis with exercise stress testing in heart failure with preserved ejection fraction
Yuki Saito, Masaru Obokata, Tomonari Harada, et al.
European Journal of Preventive Cardiology (2023) Vol. 30, Iss. 9, pp. 902-911
Closed Access | Times Cited: 18
Page 1 - Next Page

Scroll to top